These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30602460)

  • 1. HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.
    Arora J; McLaren PJ; Chaturvedi N; Carrington M; Fellay J; Lenz TL
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):944-949. PubMed ID: 30602460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
    Rolland M; Heckerman D; Deng W; Rousseau CM; Coovadia H; Bishop K; Goulder PJ; Walker BD; Brander C; Mullins JI
    PLoS One; 2008 Jan; 3(1):e1424. PubMed ID: 18183304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolutionary selective advantage of HIV-1 escape variants and the contribution of escape to the HLA-associated risk of AIDS progression.
    Asquith B
    PLoS One; 2008; 3(10):e3486. PubMed ID: 18941529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.
    Sundaramurthi JC; Swaminathan S; Hanna LE
    Immunogenetics; 2012 Oct; 64(10):767-72. PubMed ID: 22810271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.
    Arora J; Pierini F; McLaren PJ; Carrington M; Fellay J; Lenz TL
    Mol Biol Evol; 2020 Mar; 37(3):639-650. PubMed ID: 31651980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).
    Lazaro E; Tram LT; Bellecave P; Guidicelli GL; Anies G; Thu HH; Debelleix MP; Vray M; Recordon-Pinson P; Taupin JL; Lien TT; Fleury H
    PLoS One; 2011; 6(10):e26244. PubMed ID: 22039450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.
    Stranzl T; Larsen MV; Lund O; Nielsen M; Brunak S
    PLoS One; 2012; 7(9):e38670. PubMed ID: 23049726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.
    De Groot AS; Jesdale B; Martin W; Saint Aubin C; Sbai H; Bosma A; Lieberman J; Skowron G; Mansourati F; Mayer KH
    Vaccine; 2003 Oct; 21(27-30):4486-504. PubMed ID: 14505932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
    Altfeld M; Kalife ET; Qi Y; Streeck H; Lichterfeld M; Johnston MN; Burgett N; Swartz ME; Yang A; Alter G; Yu XG; Meier A; Rockstroh JK; Allen TM; Jessen H; Rosenberg ES; Carrington M; Walker BD
    PLoS Med; 2006 Oct; 3(10):e403. PubMed ID: 17076553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1.
    Carlson JM; Listgarten J; Pfeifer N; Tan V; Kadie C; Walker BD; Ndung'u T; Shapiro R; Frater J; Brumme ZL; Goulder PJ; Heckerman D
    J Virol; 2012 May; 86(9):5230-43. PubMed ID: 22379086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
    Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B; Mori M; Tanaka M; Nishimura S; Miura T; Pathipvanich P; Sawanpanyalert P; Ariyoshi K
    PLoS One; 2012; 7(7):e41696. PubMed ID: 22848569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.